The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp, giving patients a less painful option ...
Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback